Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age) a scientific statement from the american heart association and the American College of cardiology

Circulation

Volumn 130, Issue 15, 2014, Pages 1303-1334

  Maron, Barry J ^a   Friedman, Richard A ^a   Kligfield, Paul ^a   Levine, Benjamin D ^a   Viskin, Sami ^a   Chaitman, Bernard R ^a   Okin, Peter M ^a   Saul, J Philip ^a   Salberg, Lisa ^a   Van Hare, George F ^a   Soliman, Elsayed Z ^a   Chen, Jersey ^a   Matherne, G Paul ^a   Bolling, Steven F ^a   Mitten, Matthew J ^a   Caplan, Arthur ^a   Balady, Gary J ^a   Thompson, Paul D ^a  

^a NONE

Author keywords

AHA scientific statements; Cardiomyopathy; Electrocardiogram; Genetics; Screening; Sudden death

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FAMILY HISTORY; HEALTH CARE COST; HEALTH CARE INDUSTRY; HEALTH CARE SYSTEM; HEART ARREST; HUMAN; MEDICAL SOCIETY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SICKLE CELL TRAIT; SOLDIER; SPORT; SUDDEN CARDIAC DEATH; SUDDEN INFANT DEATH SYNDROME; UNITED STATES; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; AGE; CARDIOVASCULAR DISEASES; CHILD; ELECTROCARDIOGRAPHY; MASS SCREENING; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CHILD; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING; YOUNG ADULT;

EID: 84927173082     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000025     Document Type: Article

References (288)

1. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349: 1064-75.
2. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-92.
3. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2007;115:1643-55.
4. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593-601.
5. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516-24.
6. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 1996;276:199-204.
7. Maron BJ, Zipes DP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1312-75.
8. Maron BJ, Spirito P, Shen W-K, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405-12.
9. Maron BJ, Shen W-K, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-73.
10. Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-91.
11. Maron BJ, Spirito P, Ackerman MJ, et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61:1527-35.
12. Horner JM, Kinoshita M, Webster TL, et al. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. Heart Rhythm. 2010;7:1616-22.
13. Bhonsale A, James CA, Tichnell C, et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011;58:1485-96.
14. Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122:1144-52.
15. Chaitman BR. An electrocardiogram should not be included in routine preparticipation screening of young athletes. Circulation. 2007;116:2610-4.
16. Drezner JA. ECG screening in athletes: time to develop infrastructure. Heart Rhythm. 2011;8:1560-1.
17. Maron BJ. How should we screen competitive athletes for cardiovascular disease? Eur Heart J. 2005;26:428-30.
18. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-9.
19. Corrado D, Basso C, Thiene G. Sudden cardiac death in athletes: what is the role of screening? Curr Opin Cardiol. 2012;27:41-8.
20. Glover DW, Glover DW, Maron BJ. Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol. 2007;100:1709-12.
21. Corrado D, Thiene G. Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm. 2007;4:520-4.
22. Glover DW, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes. JAMA. 1998;279:1817-9.
23. Kaltman JR, Thompson PD, Lantos J, et al. Screening for sudden cardiac death in the young: report from a National Heart, Lung, and Blood Institute Working Group. Circulation. 2011;123:1911-8.
24. Link MS, Estes NA 3rd. Sudden cardiac death in the athlete: bridging the gaps between evidence, policy, and practice. Circulation. 2012;125:2511-6.
25. Maron BJ. Counterpoint: mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012;9:1646-9.
26. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med. 1998;129:379-86.
27. Pelliccia A, Corrado D. The Israel screening failure: analyzing the data to understand the results. J Am Coll Cardiol. 2011;58:989-90.
28. Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57:1291-6.
29. Viskin S. Antagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm. 2007;4:525-8.
30. Drezner JA. Standardised criteria for ECG interpretation in athletes: a practical tool. Br J Sports Med. 2012;46(suppl 1):i6-8.
31. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1981-9.
32. Corrado D, Migliore F, Zorzi A, et al. Preparticipation electrocardiographic screening for the prevention of sudden death in sports medicine [in Italian]. G Ital Cardiol (Rome). 2011;12:697-706.
33. Corrado D, Biffi A, Basso C, et al. 12-Lead ECG in the athlete: physiological versus pathological abnormalities. Br J Sports Med. 2009;43:669-76.
34. Thiene G, Corrado D, Rigato I, Basso C. Why and how to support screening strategies to prevent sudden death in athletes. Cell Tissue Res. 2012;348:315-8.
35. Schwartz PJ, Corrado D. Sudden cardiac death in young competitive athletes. Eur Heart J. 2012;33:1986-8.
36. Thiene G, Carturan E, Corrado D, Basso C. Prevention of sudden cardiac death in the young and in athletes: dream or reality? Cardiovasc Pathol. 2010;19:207-17.
37. Pelliccia A, Corrado D. Can electrocardiographic screening prevent sudden death in athletes? Yes. BMJ 2010;341:c4923.
38. Pelliccia A. The preparticipation cardiovascular screening of competitive athletes: is it time to change the customary clinical practice? Eur Heart J. 2007;28:2703-5.
39. Corrado D, Basso C, Thiene G. Comparison of United States and Italian experiences with sudden cardiac deaths in young competitive athletes: are the athletic populations comparable? Am J Cardiol. 2010;105:421-2.
40. Corrado D, Migliore F, Bevilacqua M, et al. Sudden cardiac death in athletes: can it be prevented by screening? Herz. 2009;34:259-66.
41. Corrado D, Schmied C, Basso C, et al. Risk of sports: do we need a preparticipation screening for competitive and leisure athletes? Eur Heart J. 2011;32:934-44.
42. Bjørnstad H, Corrado D, Pelliccia A. Prevention of sudden death in young athletes: a milestone in the history of sports cardiology. Eur J Cardiovasc Prev Rehabil. 2006;13:857-8.
43. Pelliccia A, Corrado D. Electrocardiography and preparticipation screening of competitive high school athletes. Ann Intern Med. 2010;153:132.
44. Campbell RM, Berger S, Drezner J. Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation. Br J Sports Med. 2009;43:336-41.
45. Asif IM, Drezner JA. Sudden cardiac death and preparticipation screening: the debate continues in support of electrocardiogram-inclusive preparticipation screening. Prog Cardiovasc Dis. 2012;54:445-50.
46. Drezner J, Corrado D. Is there evidence for recommending electrocardiogram as part of the pre-participation examination? Clin J Sport Med. 2011;21:18-24.
47. Drezner JA. Contemporary approaches to the identification of athletes at risk for sudden cardiac death. Curr Opin Cardiol. 2008;23:494-501.
48. Wilson MG, Drezner JA. Sports cardiology: current updates and new directions. Br J Sports Med. 2012;46(suppl 1):i2-4.
49. Drezner JA. Detect, manage, inform: a paradigm shift in the care of athletes with cardiac disorders? Br J Sports Med. 2013;47:4-5.
50. Drezner J, Berger S, Campbell R. Current controversies in the cardiovascular screening of athletes. Curr Sports Med Rep. 2010;9:86-92.
51. Asif IM, Rao AL, Drezner JA. Sudden cardiac death in young athletes: what is the role of screening? Curr Opin Cardiol. 2013;28:55-62.
52. Drezner JA, Asif IM, Owens DS, et al. Accuracy of ECG interpretation in competitive athletes: the impact of using standardised ECG criteria. Br J Sports Med. 2012;46:335-40.
53. Maron BJ. Does preparticipation cardiovascular screening of athletes save lives? Nat Clin Pract Cardiovasc Med. 2007;4:240-1.
54. Maron BJ. Diversity of views from Europe on national preparticipation screening for competitive athletes. Heart Rhythm. 2010;7:1372-3.
55. Maron BJ. National electrocardiography screening for competitive athletes: feasible in the United States? Ann Intern Med. 2010;152:324-6.
56. Rausch CM, Phillips GC. Adherence to guidelines for cardiovascular screening in current high school preparticipation evaluation forms. J Pediatr. 2009;155:584-6.
57. Marek JC. Electrocardiography and preparticipation screening of competitive high school athletes. Ann Intern Med. 2010;153:131-2.
58. Patel A, Lantos JD. Can we prevent sudden cardiac death in young athletes: the debate about preparticipation sports screening. Acta Paediatr. 2011;100:1297-301.
59. Thompson PD. Preparticipation screening of competitive athletes: seeking simple solutions to a complex problem. Circulation. 2009;119:1072-4.
60. Bahr R. Can electrocardiographic screening prevent sudden death in athletes? No. BMJ. 2010;341:c4914.
61. Panhuyzen-Goedkoop NM. Preparticipation cardiovascular screening in young athletes. Br J Sports Med. 2009;43:629-30.
62. Myerburg RJ, Vetter VL. Electrocardiograms should be included in preparticipation screening of athletes. Circulation. 2007;116:2616-26.
63. Bar-Cohen Y, Silka MJ. The pre-sports cardiovascular evaluation: should it depend on the level of competition, the sport, or the state? Pediatr Cardiol. 2012;33:417-27.
64. Estes NA 3rd, Link MS. Preparticipation athletic screening including an electrocardiogram: an unproven strategy for prevention of sudden cardiac death in the athlete. Prog Cardiovasc Dis. 2012;54:451-4.
65. Weiner RB, Baggish AL. Accuracy of ECG-inclusive preparticipation screening in athletes: more work to be done. Exp Rev Cardiovasc Ther. 2012;10:671-3.
66. Linder CW, DuRant RH, Seklecki RM, Strong WB. Preparticipation health screening of young athletes: results of 1268 examinations. Am J Sports Med. 1981;9:187-93.
67. Vaseghi M, Ackerman MJ, Mandapati R. Restricting sports for athletes with heart disease: are we saving lives, avoiding lawsuits, or just promoting obesity and sedentary living? Pediatr Cardiol. 2012;33:407-16.
68. Myerson M, Sanchez-Ross M, Sherrid MV. Preparticipation athletic screening for genetic heart disease. Prog Cardiovasc Dis. 2012;54:543-52.
69. Papadakis M, Whyte G, Sharma S. Preparticipation screening for cardiovascular abnormalities in young competitive athletes. BMJ. 2008;337:a1596.
70. Papadakis M, Chandra N, Sharma S. Controversies relating to preparticipation cardiovascular screening in young athletes: time for a realistic solution? Br J Sports Med. 2011;45:165-6.
71. Sharma S, Ghani S, Papadakis M. ESC criteria for ECG interpretation in athletes: better but not perfect. Heart. 2011;97:1540-1.
72. Campbell RM. Preparticipation screening and preparticipation forms. Pacing Clin Electrophysiol. 2009;32(suppl 2);S15-8.
73. Bar-Cohen Y, Silka MJ. Sudden cardiac death in pediatrics. Curr Opin Pediatr. 2008;20:517-21.
74. Thompson PD, Levine BD. Protecting athletes from sudden cardiac death. JAMA. 2006;296:1648-50.
75. Perez M, Fonda H, Le V-V, et al. Adding an electrocardiogram to the preparticipation examination in competitive athletes: a systematic review. Curr Probl Cardiol. 2009;34:586-662.
76. Lawless CE, Best TM. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med Sci Sports Exerc. 2008;40:787-98.
77. Corrado D, Basso C, Thiene G. Pros and cons of screening for sudden cardiac death in sports. Heart. 2013;99:1365-73.
78. Thiene G, Corrado D, Schiavon M, Basso C. Screening of competitive athletes to prevent sudden death: implement programmes now. Heart. 2013;99:304-6.
79. Dougherty KR, Friedman RA, Link MS, Estes NA 3rd. Prediction and prevention of sudden death in young populations: the role of ECG screening. J Interv Card Electrophysiol. 13;36:167-75.
80. Drezner JA, Ashley E, Baggish AL, et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy. Br J Sports Med. 2013;47:137-52.
81. Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med. 2013;47:153-67.
82. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the "Seattle Criteria." Br J Sports Med. 2013;47:122-4.
83. Corrado D, McKenna WJ. Appropriate interpretation of the athlete's electrocardiogram saves lives as well as money. Eur Heart J. 2007;28:1920-2.
84. Asif IM, Drezner JA. Detecting occult cardiac disease in athletes: history that makes a difference. Br J Sports Med. 2013;47:669.
85. Drezner JA, Levine BD, Vetter VL. Reframing the debate: screening athletes to prevent sudden cardiac death. Heart Rhythm. 2013;10:454-5.
86. Corrado D, Basso C, Thiene G, Pelliccia A. Incidence of sports-related sudden cardiac death: the Danish paradox. Heart Rhythm. 2010;7:1917-8.
87. Mahle WT, Sable CA, Matherne PG, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young. Key concepts in the evaluation of screening approaches for heart disease in children and adolescents: a science advisory from the American Heart Association. Circulation. 2012;125:2796-801.
88. Maron BJ, Bodison SA, Wesley YE, et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 1987;10:1214-21.
89. Lewis JF, Maron BJ, Diggs JA, et al. Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. Am J Cardiol. 1989;64:1029-33.
90. Paterick TE, Jan MF, Paterick ZR, et al. Cardiac evaluation of collegiate student athletes: a medical and legal perspective. Am J Med. 2012;125:742-52.
91. Baggish AL, Hutter AM Jr, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med. 2010;152:269-75.
92. Halkin A, Steinvil A, Rosso R, et al. Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost? J Am Coll Cardiol. 2012;60:2271-6.
93. Yanai O, Phillips ED, Hiss J. Sudden cardiac death during sport and recreational activities in Israel. J Clin Forensic Med. 2000;7:88-91.
94. Thünenkütter T, Schmied C, Dvorak J, Kindermann W. Benefits and limitations of cardiovascular pre-competition screening in international football. Clin Res Cardiol. 2010;99:29-35.
95. Wisten A, Messner T. Symptoms preceding sudden cardiac death in the young are common but often misinterpreted. Scand Cardiovasc J. 2005;39:143-9.
96. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol. 2008;51:1033-9.
97. Ma JZ, Dai J, Sun B, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death in China. J Sci Med Sport. 2007;10:227-33.
98. Bessem B, Groot FP, Nieuwland W. The Lausanne recommendations: a Dutch experience. Br J Sport Med. 2009;43:708-15.
99. Marijon E, Tafflet M, Celermajer DS, et al. Sports-related sudden death in the general population. Circulation. 2011;124:672-81.
100. Holst AG, Winkel BG, Theilade J, et al. Incidence and etiology of sportsrelated sudden cardiac death in Denmark: implications for preparticipation screening. Heart Rhythm. 2010;7:1365-71.
101. Tanaka Y, Yoshinaga M, Anan R, et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc. 2006;38:2-6.
102. Haneda N, Mori C, Nishio T, et al. Heart diseases discovered by mass screening in the schools of Shimane Prefecture over a period of 5 years. Jpn Circ J. 1986;50:1325-9.
103. Bille K, Figueiras D, Schamasch P, et al. Sudden cardiac death in athletes: the Lausanne recommendations. Eur J Cardiovasc Prev Rehabil 2006;13:859-75.
104. Hevia AC, Fernández MM, Palacio JMA, et al. ECG as a part of the preparticipation screening programme: an old and still present international dilemma. Br J Sports Med. 2011;45:776-9.
105. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young), American Heart Association. Circulation. 1996;94:850-6.
106. National Federation of State High School Associations. High school athletic participation survey. http://www.nfhs.org/participation/. Accessed February 1, 2012.
107. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-63.
108. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220-8.
109. La Gerche A, Baggish AL, Knuuti J, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging. 2013;6:993-1007.
110. Corrado D, Basso C, Thiene G. Letter by Corrado et al regarding article, "Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006." Circulation. 2009;120:e143.
111. Harris KM, Sponsel A, Hutter AM, Maron BJ. Brief communication: cardiovascular screening practices of major North American professional sports teams. Ann Intern Med. 2006;145:507-11.
112. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association. Circulation. 1998;97:2294.
113. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities: general considerations. J Am Coll Cardiol. 2005;45:1318-21.
114. Madsen NL, Drezner JA, Salerno JC. Sudden cardiac death screening in adolescent athletes: an evaluation of compliance with national guidelines. Br J Sports Med. 2013;47:172-7.
115. American Academy of Family Physicians, American Academy of Pediatrics, American College of Sports Medicine, American Medical Society for Sports Medicine, American Orthopaedic Society for Sports Medicine, American Osteopathic Academy of Sports Medicine. Preparticipation Physical Evaluation. 4th ed. Bernhardt DT, Roberts WO, eds. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
116. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol. 1995;75:827-9.
117. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41:974-80.
118. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493-501.
119. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381:242-55.
120. Van Camp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-7.
121. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334:1039-44.
122. Maron BJ, Roberts WC, McAllister HA, et al. Sudden death in young athletes. Circulation. 1980;62:218-29.
123. Choi K, Pan YP, Pock M, Chang R-K. Active surveillance of sudden cardiac death in young athletes by periodic Internet searches. Pediatr Cardiol. 2013;34:1816-22.
124. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761-96.
125. Maron BJ, Haas TS, Murphy CJ, et al. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014;63:1636-43. 125a.
126. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. State-of-the Art. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 2014;64:83-99.
127. Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation. 2011;123:1594-600.
128. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013;10:374-7.
129. Marijon E, Bougouin W, Celermajer DS, et al. Characteristics and outcome of sudden cardiac arrest during sports in women. Circ Arrhythm Electrophysiol. 2013;6:1185-91.
130. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol. 1998;32:1881-4.
131. Maron BJ, Haas TS, Doerer JJ, et al. Comparison of U.S and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009;104:276-80.
132. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-33.
133. Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57:1-134.
134. Section 3.1: lightning fatalities, injuries, and damage reports in the United States. National Lightning Safety Institute Web site. Available at: http://www.lightningsafety.com/nlsi-lls/fatalities-us.html. Accessed April 12, 2010.
135. Lightning fatalities. National Weather Service/Lightning Safety Web site. Available at: http://www.lightningsafety.noaa.gov/fatalities.htm. Accessed January 24, 2012.
136. Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple cause of death 2005-2006. CDC WONDER Online Database [database online]. Released February 2010. Available at: http:// wonder.cdc.gov/mcd.html. Accessed January 20, 2014.
137. Colorado Avalanche Information Center. Fatalities by age, 1996-2006. Available at: http://avalanche.state.co.us/wp-content/uploads/2013/09/ Slide10.jpg. Accessed January 9, 2014.
138. Maron BA, Haas TS, Maron BJ. Sudden death from collapsing sand holes. N Engl J Med 2007;356:2655-6.
139. Harris KM, Haas TS, Eichner ER, Maron BJ. Sickle cell trait associated with sudden death in competitive athletes. Am J Cardiol. 2012;110: 1185-8.
140. National Safety Council. National Safety Council estimates that at least 1.6 million crashes each year involve drivers using cell phones and texting. Washington, DC: National Safety Council; January 12, 2010. Available at: http://www.nsc.org/pages/NSCestimates16million crashescausebydriversusingcellphonesandtexting.aspx. Accessed January 24, 2012.
141. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol. 1985;5:118B-21B. 140a.
142. Pilmer CM, Kirsh JA, Hildebrandt D, Krahn AD, Gow RM. Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm 2014;11:239-45.
143. Angelini P, Elayda MA, Lawless CE. Letter by Angelini et al regarding article, "Incidence of sudden cardiac death in the National Collegiate Athletic Association." Circulation. 2011;124:e485.
144. Maron BJ, Haas TS, Ahluwalia A, et al. Increasing survival rate from commotio cordis. Heart Rhythm. 2013;10:219-23.
145. Drezner JA, Rao AL, Heistand J, et al. Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation. 2009;120:518-25.
146. Harris KM, Henry JT, Rohman E, et al. Sudden death during the triathlon. JAMA. 2010;303:1255-7.
147. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol. 2005;46:1373-4.
148. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol. 1996;28:428-31.
149. Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during longdistance running races. N Engl J Med. 2012;366:130-40.
150. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114:1633-44.
151. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes. Br J Sport Med. 2009;43:631-43.
152. Dvorak J, Grimm K, Schmied C, Junge A. Development and implementation of a standardized precompetition medical assessment of international elite football players: 2006 FIFA World Cup Germany. Clin J Sport Med. 2009;19:316-21.
153. Atkins DL, Everson-Stewart S, Sears GK, et al. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. Circulation. 2009;119:1484-91.
154. Bardai A, Berdowski J, van der Werf C, et al. Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children: a comprehensive, prospective, population-based study in the Netherlands. J Am Coll Cardiol. 2011;57:1822-8.
155. Meyer L, Stubbs B, Fahrenbruch C, et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation. 2012;126:1363-72.
156. Chugh SS, Reinier K, Balaji S, et al. Population-based analysis of sudden death in children: the Oregon Sudden Unexpected Death Study. Heart Rhythm. 2009;6:1618-22.
157. Risgaard B, Winkel BG, Jabbari R, Glinge C, Ingemann-Hansen O, Thomsen JL, Ottesen GL, Haunsø S, Holst AG, Tfelt-Hansen J. Sportsrelated sudden cardiac death in a competitive and a noncompetitive athlete population aged 12 to 49 years: data from an unselected nationwide study in Denmark [published online ahead of print May 23, 2014]. Heart Rhythm. doi: http://dx.doi.org/10.1016/j.hrthm.2014.05.026. Accessed July 17, 2014.
158. Eckart RE, Scoville SL, Campbell CL, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004;141:829-34.
159. Eckart RE, Shry EA, Burke AP, et al; Department of Defense Cardiovascular Death Registry Group. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58:1254-61.
160. Army Regulation 40-504. Standards of Medical Fitness. Rapid Action Revision issue date 2010.
161. Army Regulation 40-501. Standards of Medical Fitness. Rapid Action Revision issue date 2010.
162. Nistri S, Thiene G, Basso C, et al. Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol. 2003;91:1021-3.
163. Maron BJ, Clark CE, Goldstein RE, Epstein SE. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation. 1976;54:423-30.
164. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Eng J Med.1998;338:1709-14.
165. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761-7.
166. Tan B-H, Pundi KN, Van Norstrand DW, et al. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm. 2010;7:771-8.
167. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264-9.
168. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007;115:361-7.
169. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343:262-7.
170. Chang R-KR, Rodriguez S, Gurvitz MZ. Electrocardiogram screening of infants for long-QT syndrome: survey of pediatric cardiologists in North America. J Electrocardiol. 2010;43:4-7.
171. Tasaki H, Hamasaki Y, Ichimaru T. Mass screening for heart disease of school children in Saga City: 7-year follow up study. Jpn Circ J. 1987;51:1415-20.
172. Harmon KG, Drezner JA, Klossner D, Asif IM. Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator. Br J Sports Med. 2012;46:325-30.
173. Bonham VL, Dover GJ, Brody LC. Screening student athletes for sickle cell trait: a social and clinical experiment. N Engl J Med. 2010;363:997-9.
174. Steinberg MH. Sickle cell disease. Ann Intern Med. 2011;155:ITC3-1-16.
175. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med. 2008;42:207-11.
176. Drezner JA, Fudge J, Harmon KG, et al. Warning symptoms and family history in children and young adults with sudden cardiac arrest. J Am Board Fam Med. 2012;25:408-15.
177. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982;65:1388-94.
178. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-9.
179. Gómez JE, Lantry BR, Saathoff KN. Current use of adequate preparticipation history forms for heart disease screening of high school athletes. Arch Pediatr Adolesc Med Jul. 1999;153:723-6.
180. Pfister GC, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA. 2000;283:1597-9.
181. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006;98:1507-11.
182. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electrocardiogram of young athletes. Circulation. 2011;124:746-57.
183. Weiner RB, Hutter AM, Wang F, et al. Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in athletes. Heart. 2011;97:1573-7.
184. Corrado D, Drezner J, Basso C, et al. Strategies for the prevention of sudden cardiac death during sports. Eur J Cardiovasc Prev Rehabil. 2011;18:197-208.
185. Le V-V, Wheeler MT, Mandic S, et al. Addition of the electrocardiogram to the preparticipation examination of college athletes. Clin J Sport Med. 2010;20:98-105.
186. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31:243-59. Erratum in: Eur Heart J. 2010;31:379.
187. Hill AC, Miyake CY, Grady S, Dubin AM. Accuracy of interpretation of preparticipation screening electrocardiograms. J Pediatr. 2011;159:783-8.
188. Montgomery JV, Harris KM, Casey SA, et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005;96:270-5.
189. Franklin BA, Fletcher GF, Gordon NF, et al. Cardiovascular evaluation of the athlete: issues regarding performance, screening and sudden cardiac death. Sports Med. 1997;24:97-119.
190. Rifkin RD, Hood WB Jr. Bayesian analysis of electrocardiographic exercise stress testing. N Engl J Med. 1977;297:681-6.
191. Selzer A. The Bayes theorem and clinical electrocardiography. Am Heart J. 1981;101:360-3.
192. Rowin EJ, Maron BJ, Appelbaum E, et al. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012:110:1027-32.
193. Pelliccia A, Di Paolo FM, Corrado D, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006;27:2196-200.
194. Kligfield P, Hancock EW, Helfenbein ED, et al. Relation of QT interval measurements to evolving automated algorithms from different manufacturers of electrocardiographs. Am J Cardiol. 2006;98:88-92.
195. Kligfield P, Gettes LS, Bailey JJ, et al. Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation. 2007;115:1306-24.
196. Bailey JJ, Berson AS, Garson A, et al. Recommendations for standardization and specifications in automated electrocardiography: bandwidth and digital signal processing: a report for health professionals by an ad hoc writing group of the Committee on Electrocardiography and Cardiac Electrophysiology of the Council on Clinical Cardiology, American Heart Association. Circulation. 1990;81:730-9.
197. Kligfield P, Okin PM. Prevalence and clinical implications of improper filter settings in routine electrocardiography. Am J Cardiol. 2007;99:711-3.
198. Rijnbeek PR, Kors JA, Witsenburg M. Minimum bandwidth requirements for recording of pediatric electrocardiograms. Circulation. 2001;104:3087-90.
199. Rijnbeek PR, Witsenburg M, Schrama E, et al. New normal limits for the paediatric electrocardiogram. Eur Heart J. 2001;22:702-11.
200. Macfarlane PW, Coleman EN, Pomphrey EO, et al. Normal limits of the high-fidelity pediatric ECG: preliminary observations. J Electrocardiol. 1989;22:162-8.
201. Bragg-Remschel DA, Anderson CM, Winkle RA. Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis. Am Heart J. 1982;103:20-31.
202. Berson AS, Pipberger HV. The low-frequency response of electrocardiographs, a frequent source of recording errors. Am Heart J. 1966;71:779-89.
203. Batchvarov VN, Malik M, Camm AJ. Incorrect electrode cable connection during electrocardiographic recording. Europace. 2007;9:1081-90.
204. Heden B. Electrocardiographic lead reversal. Am J Cardiol. 2001;87:126-7.
205. Edenbrandt L, Rittner R. Recognition of lead reversals in pediatric electrocardiograms. Am J Cardiol. 1998;82:1290-2, A10.
206. Herman MV, Ingram DA, Levy JA, et al. Variability of electrocardiographic precordial lead placement: a method to improve accuracy and reliability. Clin Cardiol. 1991;14:469-76.
207. Kerwin AJ, McLean R, Tegelaar H. A method for the accurate placement of chest electrodes in the taking of serial electrocardiographic tracings. Can Med Assoc J. 1960;82:258-61.
208. Wenger W, Kligfield P. Variability of precordial electrode placement during routine electrocardiography. J Electrocardiol. 1996;29:179-84.
209. Schijvenaars BJ, Kors JA, van Herpen G, et al. Effect of electrode positioning on ECG interpretation by computer. J Electrocardiol. 1997;30:247-56.
210. Lateef F, Nimbkar N, Da ZK, Min FR. Vertical displacement of the precordial leads alters electrocardiographic morphology. Indian Heart J. 2003;55:339-43.
211. Farb A, Devereux RB, Kligfield P. Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy. J Am Coll Cardiol. 1990;15:618-23.
212. Angeli F, Verdecchia P, Angeli E, et al. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients: influence of electrode placement. J Cardiovasc Med. 2006;7:812-6.
213. Van Den Hoogen JP, Mol WH, Kowsoleea A, et al. Reproducibility of electrocardiographic criteria for left ventricular hypertrophy in hypertensive patients in general practice. Eur Heart J. 1992;13:1606-10.
214. Azie NE, Adams G, Darpo B, et al. Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies. Ann Noninvasive Electrocardiol. 2004;9:166-74.
215. Kautzner J. QT interval measurements. Card Electrophysiol Rev. 2002;6:273-7.
216. Viskin S, Rosovski U, Sands AJ, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm. 2005;2:569-74.
217. Miller MD, Porter CJ, Ackerman MJ. Diagnostic accuracy of screening electrocardiograms in long QT syndrome I. Pediatrics. 2001;108:8-12.
218. Kligfield P, Tyl B, Maarek M, Maison-Blanche P. Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes. Ann Noninvasive Electrocardiol. 2007;12:145-52.
219. Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70:797-801.
220. Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol. 2001;12:411-20.
221. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol. 2004;37(suppl):81-90.
222. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation. 2000;102:278-84.
223. Gademan MG, Uberoi A, Le VV, et al. The effect of sport on computerized electrocardiogram measurements in college athletes. Eur J Prev Cardiol. 2012;19:126-38.
224. Migliore F, Zorzi A, Michieli P, et al. Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation. 2012;125:529-38.
225. Dadlani GH, Wilkinson JD, Ludwig DA, et al. A high school-based voluntary cardiovascular risk screening program: issues of feasibility and correlates of electrocardiographic outcomes. Pediatr Cardiol. 2013;34:1612-9.
226. Pelliccia A, Culasso F, Di Paolo FM, et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J. 2007;28:2006-10.
227. Drezner JA, Fischbach P, Froelicher V, et al. Normal electrocardiographic findings: recognising physiological adaptations in athletes. Br J Sports Med. 2013;47:125-36.
228. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008;51:2250-5.
229. Choo JK, Abernethy WB 3rd, Hutter AM Jr. Electrocardiographic observations in professional football players. Am J Cardiol. 2002;90:198-200.
230. Magalski A, McCoy M, Zabel M, et al. Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes. Am J Med. 2011;124:511-8.
231. Malhotra R, West JJ, Dent J, et al. Cost and yield of adding electrocardiography to history and physical in screening Division I intercollegiate athletes: a 5-year experience. Heart Rhythm. 2011;8:721-7.
232. Marek J, Bufalino V, Davis J, et al. Feasibility and findings of largescale electrocardiographic screening in young adults: data from 32,561 subjects. Heart Rhythm. 2011;8:1555-9.
233. Brosnan M, La Gerche A, Kalman J, et al. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes. Br J Sports Med. 2013: published online before print June 27, 2013, doi:10.1136/bjsports-2013-092420. Accessed July 20, 2013.
234. Chandra N, Bastiaenen R, Papadakis M, et al. The prevalence of ECG anomalies in young individuals; relevance to a nationwide cardiac screening program [published online ahead of print February 14, 2014]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2014.01.046.
235. Rosso R, Glikson E, Belhassen B, et al. Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology. Heart Rhythm. 2012;9:225-9.
236. Noseworthy PA, Weiner R, Kim J, et al. Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise training. Circ Arrhythm Electrophysiol. 2011;4:432-40.
237. Leo T, Uberoi A, Jain NA, et al. The impact of ST elevation on athletic screening. Clin J Sport Med. 2011;21:433-40.
238. Macarie C, Stoian I, Dermengiu D, et al. The electrocardiographic abnormalities in highly trained athletes compared to the genetic study related to causes of unexpected sudden cardiac death. J Med Life. 2009;2:361-72.
239. Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358:152-61.
240. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:1422-45.
241. Di Paolo FM, Schmied C, Zerguini YA, et al. The athlete's heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol. 2012;59:1029-36.
242. Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J. 2011;32:2304-13.
243. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256-62.
244. Sheikh N, Papadakis M, Ghani S, et al. Limitations of current electrocardiographic interpretation recommendations in young elite athletes: a call for a paradigm shift with focus on African and Afro-Caribbean ethnicity. Circulation. In press.
245. Papadakis M, Wilson MG, Ghani S, et al. Impact of ethnicity upon cardiovascular adaptation in competitive athletes: relevance to preparticipation screening. Br J Sports Med. 2012;46(suppl 1):i22-8.
246. Vetter VL, Dugan N, Guo R, et al. A pilot study of the feasibility of heart screening for sudden cardiac arrest in healthy children. Am Heart J. 2011;161:1000-1006.e3.
247. Comitato Organizzativo Cardiologico per l'Idoneita Allo Sport (COCIS). Cardiologic protocols for judging fitness for competition sports [in Italian]. G Ital Cardiol. 1989;19:250-72.
248. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167:492-9.
249. Israel Ministry of Health athlete pre-participation medical screening guidelines. Ministry of Health Web site. Available at: http://www.health. gov.il. Accessed September 29, 2010.
250. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol. 1976;104:493-8. 247a
251. Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ. When is critical care medicine cost-effective? A systematic review of the costeffectiveness literature. Crit Care Med 2006;34:2738-47.
252. Wheeler MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010;152:276-86.
253. Schoenbaum M, Denchev P, Vitiello B, Kaltman JR. Economic evaluation of strategies to reduce sudden cardiac death in young athletes. Pediatrics. 2012;130:e380-9.
254. Leslie LK, Cohen JT, Newburger JW, et al. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation. 2012;125:2621-9.
255. Fuller CM. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 2000;32:887-90.
256. Rodgers GM, Schleifer J, Fenrich A, et al. Texas early cardiovascular screening pilot. Report to the Texas Education Agency (TEA).
257. LaCorte MA, Boxer RA, Gottesfeld IB, et al. EKG screening program for school athletes. Clin Cardiol. 1989;12:42-4.
258. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 1997;29:1131-8.
259. Rizzo M, Spataro A, Cecchetelli C, et al. Structural cardiac disease diagnosed by echocardiography in asymptomatic young male soccer players: implications for pre-participation screening. Br J Sports Med. 2012;46:371-3.
260. Stefani L, Galanti G, Toncelli L, et al. Bicuspid aortic valve in competitive athletes. Br J Sports Med. 2008;42:31-5.
261. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. echocardiographic analysis of 4111 subjects in the CARDIA study: Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-9.
262. Maron BJ. Hypertrophic cardiomyopathy: an important global disease. Am J Med. 2004;116:63-5.
263. Coris EE, Sahebzamani F, Curtis A, et al. Preparticipation cardiovascular screening among National Collegiate Athletic Association Division I institutions. Br J Sports Med. 2013;47:182-4.
264. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005.
265. Biller-Andorno N, Juni P. Abolishing mammography screening programs? a view from the Swiss Medical Board. N Engl J Med. 2014;379:1965-67.
266. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:762-71.
267. Centers for Disease Control and Prevention (CDC). Cancer screening: United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-5.
268. Heijnsdijk EA, Wever EM, Auvinen A, et al. Quality-of-life effects of prostate-specific antigen screening. N Engl J Med. 2012;367:595-605.
269. Prasad SM, Drazer MW, Huo D, et al. 2008 U.S. Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA. 2012;307:1692-4.
270. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening randomized controlled trial. JAMA. 2011;305:2295-303.
271. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307:2418-29. Errata in: JAMA. 2012;308:1324 and JAMA. 2013;309:2212.
272. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. London, UK; 2003. http://www.screening.nhs.uk/criteria. Accessed January 10, 2012.
273. Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation. 2008;117:2407-23. Erratum in: Circulation. 2009;120:e55-9.
274. American Academy of Pediatrics/American Heart Association. American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008. J Dev Behav Pediatr. 2008;29:335.
275. Sudden cardiovascular death in sport: Lausanne recommendations. http://www.Olympic.Org/documents/reports/en/en-report-886.PDF. Accessed July 6, 2011.
276. Frankel LR, Goldworth A, Rorty MV, Silverman WA, eds. Ethical Dilemmas in Pediatrics: Cases and Commentaries. Cambridge, United Kingdom: Cambridge University Press; 2005.
277. Frankel LR, Rorty MV, Silverman WA, eds. Ethical Dilemmas in Pediatrics: Cases and Commentaries. Cambridge, United Kingdom: Cambridge University Press; 2009.
278. Whyte KP, Selinger E, Caplan AL, Sadowski J. Nudge, nudge or shove, shove: the right way for nudges to increase the supply of donated cadaver organs. Am J Bioeth. 2012;12:32-9. 274a
279. Berlan ED, Bravender T. Confidentiality, consent, and caring for the adolescent patient. Curr Opin Pediatr. 2009;21:450-6.
280. McGuire AL, Bruce CR. Keeping children's secrets: confidentiality in the physician-patient relationship. Hous J Health L & Policy. 2008;8:315-33.
281. Benesmo v Nemours Foundation, 253 F Supp 2d 801,812 (D Del 2003).
282. Mitten MJ. Emerging legal issues in sports medicine: a synthesis, summary, and analysis. St John's L Rev. 2002;76:5-86.
283. Mitten MJ. Team physicians and competitive athletes: allocating legal responsibility for athletic injuries. Univ Pitt L Rev. 1993;55:129-60.
284. Paterick TE, Paterick TJ, Fletcher GF, Maron BJ. Medical and legal issues in the cardiovascular evaluation of competitive athletes. JAMA. 2005;294:3011-8.
285. Peters PG Jr. The quiet demise of deference to custom: malpractice law at the millennium. Wash & Lee L Rev. 2000;57:163-205.
286. Dobbs DG, Hayden P, Bublick E. §295. Dobbs' Law of Torts. 2nd ed. New York, NY: Thomson Reuters; 2013.
287. Maron BJ, Mitten MJ, Quandt EF, Zipes DP. Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med. 1998;339:1632-5.
288. Knapp v Northwestern University, 101 F3d 473 (7th Cir 1996), cert denied, 520 US 1274 (1997).